People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neutrolis Inc. | — | Biotechnology | Series B | $27.6M | $16.5M | 2025 |
John Hakkim Sundy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Hakkim Sundy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Abdul Hakkim Rahamathullah | 1 | 2 |
| Gerald Hakkim Chan | 1 | 1 |
| Anthony Hakkim Aiudi | 1 | 1 |
| Toby Hakkim Fox | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.